# Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)

> **NCT01035528** · PHASE4 · UNKNOWN · sponsor: **Munich Municipal Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Coronary Artery Disease
- Type 2 Diabetes

## Interventions

- **DRUG:** insulin glargine
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT01035528
- **Lead sponsor:** Munich Municipal Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-04
- **Primary completion:** 2010-02
- **Final completion:** 2010-08
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2009-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01035528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01035528, "Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01035528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*